Poseida’s Myeloma-specific CAR T-cells Combat Aggressive Cancer in Mice, Study Shows – Myeloma Research News
Myeloma Research News |
Poseida's Myeloma-specific CAR T-cells Combat Aggressive Cancer in Mice, Study Shows
Myeloma Research News Poseida Therapeutics demonstrated that their new CAR T-cell treatment for multiple myeloma — P-BCMA-101 — possessed features that make it stand out in the field of gene-edited cancer cell therapies. The preclinical data, presented at the CAR-TCR … |
